Previous Close | 7.31 |
Open | 7.31 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 7.31 - 7.31 |
52 Week Range | 7.31 - 7.31 |
Volume | |
Avg. Volume | N/A |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Oslo, March 25, 2024, the Board of Directors hereby calls for the Annual General Meeting of Ultimovacs ASA (the "Company") at 14:00 CET on April 18, 2024. The General Meeting will be held electronically. For participation, please log in at https://dnb.lumiagm.com/137559337. All documents regarding the Annual General Meeting are available at the Company’s website: www.ultimovacs.com For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chairman of the Board of Direct
Oslo, 21 March 2024: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces that the Board of Directors of Ultimovacs ASA has approved the Annual Report and ESG Report for 2023. Please find a PDF version of the annual report, as well as the report in European Single Electronic Format (ESEF), as attachments to this release. The Annual Report is also available at the company's website: www.ultimovacs.com This informat
Oslo, 8 March 2024: CGS Holding AS, a closely related party of Leiv Askvig, a board member and primary insider in Ultimovacs ASA, has today sold 140,000 shares in the company at an average price of NOK 7.2507 per share. Following these transactions, CGS Holding AS holds 0 shares in Ultimovacs ASA. Helene Sundt AS, a closely related party of Leiv Askvig, a board member and primary insider in Ultimovacs ASA, has today sold 140,000 shares in the company at an average price of NOK 7.2507 per share.